The role of mesenchymal stem cells in anti-cancer drug resistance and tumour progression

被引：132
|
作者：
Houthuijzen, J. M. [1 ]
Daenen, L. G. M. [1 ]
Roodhart, J. M. L. [1 ]
Voest, E. E. [1 ]
机构：
[1] Univ Med Ctr Utrecht, Dept Med Oncol, NL-3508 GA Utrecht, Netherlands
来源：
BRITISH JOURNAL OF CANCER | 2012年 / 106卷 / 12期
关键词：
mesenchymal stem cells; tumour progression; drug resistance; chemotherapy resistance; ENDOTHELIAL-CELLS; LEUKEMIA CELLS; APOPTOSIS; MICROENVIRONMENT; METABOLISM; SURVIVAL; STROMA; ACID;
D O I：
10.1038/bjc.2012.201
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
It is becoming increasingly clear that the tumour microenvironment has a very important role in tumour progression and drug resistance. Many different cell types within the tumour stroma have an effect on tumour progression either in a positive or in a negative way. Mesenchymal stem cells (MSCs) are a distinct population of cells that have been linked with tumour growth. Mesenchymal stem cells can home to tumours where they modulate the immune system and facilitate tumour growth, angiogenesis and metastasis. Recent studies have shown that MSCs also have an important role in the resistance to various anti-cancer drugs. This mini-review provides an overview of the functional properties of MSCs in tumour progression and drug resistance. British Journal of Cancer (2012) 106, 1901-1906. doi:10.1038/bjc.2012.201 www.bjcancer.com Published online 17 May 2012 (C) 2012 Cancer Research UK
引用
收藏
页码：1901 / 1906
页数：6
相关论文
共 50 条
  • [1] The role of mesenchymal stem cells in anti-cancer drug resistance and tumour progression
    J M Houthuijzen
    L G M Daenen
    J M L Roodhart
    E E Voest
    British Journal of Cancer, 2012, 106 : 1901 - 1906
  • [2] Mesenchymal Stem Cells for Anti-Cancer Drug Delivery
    Gjorgieva, Darinka
    Zaidman, Nathan
    Bosnakovski, Darko
    RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2013, 8 (03) : 310 - 318
  • [3] Mesenchymal cancer stem cells: Role in tumour development and radiotherapy resistance
    D'Andrea, F. P.
    Safwat, A.
    Horsman, M.
    Overgaard, J.
    APMIS, 2008, 116 (05) : 433 - 433
  • [4] Potential of Mesenchymal Stem Cells in Anti-Cancer Therapies
    Kostadinova, Milena
    Mourdjeva, Milena
    CURRENT STEM CELL RESEARCH & THERAPY, 2020, 15 (06) : 482 - 491
  • [5] Decoding secret role of mesenchymal stem cells in regulating cancer stem cells and drug resistance
    Panda, Sameer Kumar
    Robinson, Nirmal
    Desiderio, Vincenzo
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2024, 1879 (06):
  • [6] Engineered Mesenchymal Stem Cells as an Anti-Cancer Trojan Horse
    Nowakowski, Adam
    Drela, Katarzyna
    Rozycka, Justyna
    Janowski, Miroslaw
    Lukomska, Barbara
    STEM CELLS AND DEVELOPMENT, 2016, 25 (20) : 1513 - 1531
  • [7] Perspectives in Engineered Mesenchymal Stem/Stromal Cells Based Anti-Cancer Drug Delivery Systems
    Ackova, Darinka Gjorgieva
    Kanjevac, Tatjana
    Rimondini, Lia
    Bosnakovski, Darko
    RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2016, 11 (01) : 98 - 111
  • [8] The role of epithelial–mesenchymal transition-regulating transcription factors in anti-cancer drug resistance
    Jihye Seo
    Jain Ha
    Eunjeong Kang
    Sayeon Cho
    Archives of Pharmacal Research, 2021, 44 : 281 - 292
  • [9] A role of undifferentiated mesenchymal stem cells in cancer progression
    Enomoto, Atsushi
    Takahashi, Masahide
    CANCER SCIENCE, 2018, 109 : 182 - 182
  • [10] Mesenchymal stem cells in cancer progression and anticancer therapeutic resistance
    Xuan, Xiuyun
    Tian, Chunxia
    Zhao, Mengjie
    Sun, Yanhong
    Huang, Changzheng
    CANCER CELL INTERNATIONAL, 2021, 21 (01)
12345